-
It's a well-accepted position in human subjects protection circles that in order to improve IRBs and their relationships with investigators, it's important to actually study IRBs how they work, how long it takes to do things, the knowledge and attitudes that members carry into discussions of various types of research.
-
When consultant Jeffrey Cooper talks to IRBs about using the flexibility of federal regulations to change their procedures, he can see that the message doesn't always get through.
-
[Editor's note: Valerie Bonham, JD, executive director of the Presidential Commission for the Study of Bioethical Issues, answers these two questions about the new International Research Panel formed this year by President Barack Obama.]
-
Human research protection program staff at the VA Medical Center in Tuscaloosa, AL, knew there was a problem with the IRB's expedited review process.
-
Everyone does more work with less time these days. So how can an IRB make new board member training effective without being time demanding? One IRB has found that the answer is to hold brief educational sessions during its board meetings.
-
Adverse drug event (ADE) reporting often is inaccurate, has omissions, and sends unnecessary information to IRBs, an expert says.
-
When a researcher breaches a cultural divide to study a group of people, he or she needs more than a translator to convert documents from one language to another.
-
How do you bridge the gap between an IRB that believes all of the work you do is subject to oversight and a faculty that thinks none of it is?
-
Five years ago, a panel of researchers and others involved in social and behavioral sciences convened to explore concerns about the scope and effectiveness of IRB review.
-
Can the informed consent process actually provide too much information?